UBS OCONNOR LLC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 3 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$2,780,000,000
-7.3%
7,500,0000.0%0.05%
+11.4%
Q3 2017$3,000,000,0000.0%7,500,0000.0%0.04%
-10.2%
Q2 2017$3,000,000,0000.0%7,500,0000.0%0.05%
-3.9%
Q1 2017$3,000,000,000
-20.0%
7,500,000
-50.0%
0.05%
-29.2%
Q4 2016$3,750,000,000
-36.8%
15,000,000
-30.0%
0.07%
-18.2%
Q3 2016$5,934,000,000
-29.8%
21,414,0000.0%0.09%
-51.6%
Q2 2016$8,452,000,000
-5.8%
21,414,0000.0%0.18%
+10.3%
Q1 2016$8,975,000,000
-28.3%
21,414,000
+3.6%
0.16%
-21.8%
Q4 2015$12,519,000,000
-6.8%
20,664,000
+8.3%
0.21%
-23.0%
Q3 2015$13,438,000,000
-10.0%
19,075,000
+18.7%
0.27%
+5.8%
Q2 2015$14,928,000,000
-13.3%
16,075,000
+7.2%
0.26%
-29.6%
Q1 2015$17,219,000,000
+79.8%
15,000,000
+57.9%
0.37%
+120.4%
Q4 2014$9,579,000,0009,500,0000.17%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
BVF INC/IL 10,000,000$3,550,0000.43%
Telemetry Investments, L.L.C. 2,500,000$875,0000.33%
UBS OCONNOR LLC 7,500,000$2,780,000,0000.05%
View complete list of OREXIGEN THERAPEUTICS INC shareholders